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Background: Escherichia coli (E.coli) has been implicated as a common cause of both early and late onset neonatal infections. 
The emergence of different strains of E.coli that are multiply resistant to commonly used antibiotics has made continuous 
antibiotics surveillance relevant. Knowledge about common infections caused by E.coli as well as its antibiotics susceptibility 
pattern will guide paediatricians in choosing appropriate antibiotics for empirical treatment of neonatal infections. 
 
Methods:  A retrospective  study of  E.coli  neonatal infections  in  NHA was  conduct  for the  period 1st   January 2010  to 31st 
December 2012. The records of all specimens submitted to the Medical Microbiology laboratory within the neonatal period (first 
28 days of life) were examined and data about E.coli isolates and their antibiotics susceptibility pattern were retrieved and 
evaluated. 
 
Results: 251(33.2%) bacteria were isolated out of a total of 757 specimen submitted for analysis within the period under review. 
17(6.8%) were E.coli; 16 were from soft tissue specimen and one from blood. There was no isolate of E.coli from CSF. Most of the 
isolates were resistant to commonly used antibiotics for treatment of neonatal infections. Three isolates were resistance to 
amoxicillin-clavulanate and ceftriaxone. One isolate was resistance to amoxicillin-clavulanate, ceftriaxone and imipenem. 100% 
and 80% of the strains tested were susceptible to amikacin and imipenem respectively. 
 
Conclusion: E.coli is third among the gram negative bacteria isolated within the period under review. Most of them were 
resistant to commonly used antibiotics for treating neonatal infections but, susceptible to amikacin and imipenem. There is 
need for regular antibiotics resistance surveillance and stewardship. 
 




Infections have been identified as the most common 
cause   of   death   in   the   neonatal   period   in   both 
developed and developing countries (1,2). These 
infections include neonatal sepsis, meningitis, 
pneumonia, and soft tissue infections.  Escherichia coli 
(E.coli)  has  been  implicated  as  one  of  the  most 
common isolates recovered from specimen submitted 
for processing due to infection in this age group(1).It 
has been implicated as a common cause of neonatal 
sepsis(1,3),  neonatal  meningitis(3),  neonatal 
bacteremia (4), and neonatal soft tissue infection(4). 
E.coli is able to cause these infections because they are 
among the first set of bacteria that colonize the 
newborn. It exists as a normal flora of the 
gastrointestinal  tract  of  human(5)  and  can  easily 
spread from  the  rectum to  the  female genital tract 
through the perineum(1,5). Vaginal E.coli colonization 
is detected in 7-13% of pregnant women and 21% in 
the blood of fetuses that have died during the third 
trimester of pregnancy (6,7). Neonates acquire E.coli 
intrapatum and during labour (5,6,7). 
 
The immune system of neonate is not fully developed 
at birth and till date, no preventive measures have 
been  advocated  for  E.coli  colonization  of  the  birth 
canal  (1).  E.coli  and  group  B  β-haemolytic 
streptococcus (GBS) are the commonest bacteria 
mentioned as a cause of early onset neonatal sepsis 
(EONS)  in  developed  countries(8).  However, 
following the introduction of late antenatal screening 
and intrapatum antibiotics prophylaxis in 1996 which 
led to a reduction in GBS, the gram negative bacteria 
such as E.coli have become prevalent as a  cause of 
EONS(8). Previous studies in  our  center implicated 
E.coli, K.pneumoniae, P.aeruginosa and S.aureus as 
common causes of infections in the neonatal period 







The occurrence of antibiotics resistance in E.coli 
continue to increase nationwide both for single and to 
multi-class  resistance  to  several  antibiotics  (multi- 
drug resistance [MDR]) (11,28). The recent trend in 
antibiotic resistance has seen the emergence of 
different strains of E.coli that elaborate resistance 
enzymes such as Extended-Spectrum Beta Lactamases 
(ESBLs)             producer, AmpC β-lactamases and 
carbapenemases that confer multiple resistance to 
commonly used antibiotics for treatment of 
infections(11,12,27,28) . These have made continuous 
antimicrobial surveillance a priority in clinical 
microbiology laboratories. 
 
The aim of this study was to evaluate the prevalence 
of E.coli as a cause of neonatal infections as well as 
their antibiotics susceptibility pattern in the last three 
years in NHA. The outcome of this study will guide 
the  paediatrician  in  the  management  of  suspected 




This  is  a   retrospective  study  carried  out  at  the 
National Hospital Abuja, a 200 bedded tertiary 
healthcare institution, located in the Federal Capital 
Territory  (FCT),  Nigeria.  It  has  a  well  equipped 
Special   Care   Baby   Unit   (SCBU)   and   Neonatal 
Intensive Care Unit (NICU).  The hospital serves as a 
tertiary healthcare and referral centre for the 
inhabitants of Abuja and neighboring states. 
 
The records of the Department of Medical 
Microbiology and Parasitology laboratory of the 
hospital from Jan. 1st 2010 to Dec. 31st 2012 were 
reviewed. All isolates from blood culture, 
Cerebrospinal  fluid  (CSF)  and  soft  tissue  (wound 
swab, eye swab, ear swab, umbilical cord, pus) 
specimens from neonates that were conclusively 
identified as pathogens were included in the study, 
while  contaminants  were  excluded.  E.coli  isolates 
were specifically reviewed with emphasis on the age, 
sex, type of specimen submitted to the laboratory for 
analysis as well as their antibiotics susceptibility 
pattern. 
 
In our facility during the study period, blood cultures 
were usually performed with Oxoid signal system 
(Oxoid,  Basingstoke, UK)  or  BACTEC 9050(Becton- 
Dickson, New Jersey, USA) continuous-monitoring 
blood   culture   systems.   CSF   analysis,   soft   tissue 
culture  and  bacterial identification were  performed 
using standard microbiology techniques (13). The 
Modified  Kirby-Bauer  disc  diffusion  method  was 
used for antibiotics susceptibility testing and 
interpreted based on the Clinical and Laboratory 




A total of 757 specimen comprising blood(245), 
CSF(127) and soft tissue(385) were submitted for 
processing    during    the    period    under    review. 
251(33.2%) pathogens were isolated, out of which 247 
(98.4%)  were  bacteria  isolates  while  4(1.6%)  were 
Candida species (Table 1). 17 (6.8%) were identified as 
E.coli; one from blood culture, non from CSF, 16 from 
soft tissue specimens (Table 2). 
 
S.aureus was the predominant bacteria isolated, 
accounting for 143 (56.5%) of the 251 isolates and the 
most frequently isolated pathogen across all the 
specimens types submitted for processing (Table 2). 
 
 
TABLE 1: YIELD OF ISOLATES BY SPECIMENS. 
 
Specimen types Total No of specimen Isolates Total 
Bacteria Candida spp 
Blood culture 245 94 2 96 
CSF 127 7 0 7 
Soft tissue 385 146 2 148 
Total 757 247(98.4%) 4(1.6%) 251(100%) 










Specimen type No. of Isolates Percentage 
Blood Culture 1 5.9% 
Wound swab 5 29.4% 
Umbilical swab 5 29.4% 
Eye swab 3 17.6% 
skin swab 2 11.8% 
Scalp swab 1 5.9% 
Total 17 100% 
 
 
TABLE 2: PATHOGENS ISOLATED FROM DIFFERENT SAMPLES. 
 
Isolates Blood culture CSF Soft tissue Total Percentage 
E.coli 1 0 16 17 6.8% 
S.pyogenes 0 0 8 8 3.2% 
S.aureus 62 4 77 143 57.0% 
Enterococcus spp 6 1 7 14 5.6% 
L.monocytogenes 1 0 0 1 0.4% 
Klebsiellae spp 8 1 12 21 8.4% 
P.aeruginosa 5 0 14 19 7.6% 
CoNS 4 0 0 4 1.6% 
Proteus spp 1 0 4 5 2.0% 
Serratia marcescens 2 0 1 3 1.2% 
Citrobacter freundii 1 0 3 4 1.6% 
M. morgagnii 1 0 2 3 1.2% 
Alcaligenes spp 2 0 1 3 1.2% 
Neisseria spp 0 1 0 1 0.4% 
Acinectobacter spp 0 0 1 1 0.4% 
Candida spp 2 0 2 4 1.6% 
Total 96 7 148 251 100% 




All the 17 isolate of E.coli were from neonates older 
than 72hours; 8 from females and 9 from males. 
Wound and umbilical swabs specimen were the 
predominant  specimen   received   (Table   3).   80%, 
81.8%, 83.3%, and 62.5% of the tested E.coli strains 
were resistant to  ampicillin, amoxicillin-clavulanate, 
gentamicin and cefuroxime respectively, while 40%, 
33.3%, 66.7% and 20% were resistant to cefotaxime, 
ceftriaxone, ceftazidime and  imipenem respectively. 
All  tested  E.coli  strains  were  sensitive to  amikacin 
(Table 4). 























TABLE 4: ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF E.COLI ISOLATED 
 
Antibiotics No tested Susceptible(%) Resistant(%) 
Ciprofloxacin 7 5(71.4) 2(28.6) 
Ofloxacin 4 2(50) 2(50) 
Cefotaxime 10 6(60) 4(40) 
Cefuroxime 8 3(37.5) 5(62.5) 
Amox-Clav. 11 2(18.2) 9(81.8) 
Genticin 6 1(16.7) 5(83.3) 
Amoxicillin 5 1(20.0) 4(80.0) 
Ceftazidime 6 2(33.3) 4(66.7) 
Imipenem 5 4(80) 1(20%) 
Amikacin 7 7(100) 0 (0) 





It has been revealed in  this study that most of  the 
E.coli isolated were from soft tissue specimens; it is 
difficult to ascertain whether they represent true 
infections or colonization of the newborn. No 
conclusion can be made concerning the only isolate 
from blood except to say that it most probably 
represent  a   true   infection.  S.aureus  is   the   most 
common bacteria cause of infections in this age group. 
It is the predominant bacterial isolate from blood 
culture, followed by K.pneumoniae. This finding is in 
agreement with similar studies from Maiduguri and 
Uganda on neonatal infections which showed S.aureus 
as the predominant pathogen, followed by Klebsiellae 
pneumonia   (15,16).   It   however,   contrast   with   a 
previous study done in this center between 2002 to 
2004  which  showed  almost  equal  representation of 
both gram negative and gram positive bacteria as 
causes of neonatal sepsis(9) and a prospective study 
in Port Harcourt which showed Klebsiella pneumonia 
as  the  predominant  isolate  (17).  S.aureus  was  the 
main bacteria isolated from CSF during the study 
period, and  this  is  in  keeping with  the  result of  a 
previous study in Jos, Nigeria (18).   The same study 
reported the absence of E.coli from CSF (18) . E.coli is a 
known cause of neonatal meningitis (3). The reason 
for this is not clear, and may require further studies. 
Although, the  coagulase negative  staphylococci 
(CoNS)  that  were  isolated  were  recorded  as 
pathogens they may as well represent contaminants. 
Difficulties exist in some cases in the differentiation of 
CoNS infection from culture contamination in clinical 
specimen  because  CoNS  is  a  common  skin 
commensal (19).  Four  of  the isolates were  candida 
specie from blood culture and soft tissue which might 
be  responsible  for  infection  in  low  birth  weight 
neonates as observed in some previous studies(20,21). 
All the isolates in this study were from the late 
neonatal   period   and   as   such,   it   is   difficult   to 
determine whether E.coli is a common cause of 
infection in the early neonatal period or not. It is 
possible that delays in decision making by the 
paediatrician with respect to submission of neonatal 
specimen for analysis whenever they suspect neonatal 
infection within 72 hours, may have inadvertently 
moved early onset infections into late onset period. 
 
The antibiotics resistant pattern in the E.coli isolated 
in this study cannot be interpreted with a high degree 
of certainty because not all the isolates were equally 
tested for resistance to the same classes of commonly 
used antibiotics in our laboratory. However, based on 
the available data, most of the isolates are resistant to 
amoxicillin,   amoxicillin-clavulanate   in    agreement 
with previous studies (9,22,23). Most were also 
resistance to the third generation cephalosporins with 
few  of  the  E.coli isolates showing resistant pattern 
resembling ESBL producers; the prevalence of which 
has been reported in other studies as11.4% (2009)and 
3.8%(2012) by Iroha et al from Enugu (24,25) , while 
76.9% was report from Ibadan in 2012(28).  The tested 
isolates were susceptible to imipenem and this agrees 
with previous studies (9,25,26,27). This may suggest 
that  strains  that  elaborates  carbapenemase enzyme 
may  not  be  common  in  this  locality.  Studies  have 
shown  that  most  Enterobacteriaceae, E.coli  inclusive; 
even the ESBL-producing strains, are still susceptible 
to the carbapenems (25,26,27,28). 
 
Seven  of  the  E.coli  strains  tested  against  amikacin 
were susceptible. Of these seven isolates, three were 
tested against imipenem, out of which two were 






imipenem were the most active antimicrobial agent 
against isolates of E.coli as found in other studies 
(27,28). 
 
In conclusion, E.coli is the fourth most common 
bacteria isolated in the neonatal period in this study 
and  third  among the  gram negative bacteria. Most 
were  resistant  to  commonly  used  antibiotics  for 
treatment of neonatal infections with a few showing 
resistant pattern resembling ESBLs producers.   Most 
of the isolates were susceptible to amikacin and the 
carbapenems. In view of the limitation encountered in 
this study, a well designed prospective study; as well 
as continuous surveillance of antimicrobial resistance 
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